Literature DB >> 2582034

Protein-antigen specific Ia-restricted cytolytic T cells: analysis of frequency, target cell susceptibility, and mechanism of cytolysis.

J P Tite, M B Powell, N H Ruddle.   

Abstract

We previously showed that cloned, antigen-specific, Ia-restricted L3T4a+ T cell lines can be cytolytic for antigen-pulsed B cell lymphoma targets. Such cells can also, under different experimental conditions, activate B cells to proliferate and secrete immunoglobulin. In the present experiments, we show that this functional phenotype is a common one among a panel of cloned T cell lines. In keeping with this finding, freshly isolated, antigen-activated lymph node T cells show similar functional properties. Such cytolytic L3T4a+ T cells differ from classical H-2K/D-restricted cytolytic T cells in two distinct ways. First, Ia-restricted cytolytic T cells can kill bystander targets, whereas H-2K/D-specific cytolytic T cells do not. Second, in testing a panel of target cells by using lectin-mediated cytolysis, Ia-restricted cytolytic clones reveal large differences in target cell susceptibility, whereas all targets are similarly susceptible to H-2K/D-specific killer cells. Finally, evidence is presented that both direct and bystander killing effected by L3T4a+ T cells are mediated by the same soluble factors, in that there is a strong positive correlation of these two activities for individual cloned lines. The relevant mediators appear to be lymphotoxin and IFN-gamma, although the latter molecule by itself is not cytolytic on our target lines.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2582034

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Differential requirement for protein synthesis in cytolysis mediated by class I and class II MHC-restricted cytotoxic T cells.

Authors:  J P Tite
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

2.  Autocrine growth inhibition of a cloned line of helper T cells.

Authors:  J B Horowitz; J Kaye; P J Conrad; M E Katz; C A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

3.  DNA fragmentation: manifestation of target cell destruction mediated by cytotoxic T-cell lines, lymphotoxin-secreting helper T-cell clones, and cell-free lymphotoxin-containing supernatant.

Authors:  D S Schmid; J P Tite; N H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

4.  Heterogeneous cytotoxic cells that kill NC-sensitive WEHI-164 tumor cells are activated in allogeneic mixed lymphocyte reactions.

Authors:  S Macphail; O Stutman
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

5.  Evidence of a role for TNF-alpha in cytolysis by CD4+, class II MHC-restricted cytotoxic T cells.

Authors:  J P Tite
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

6.  Cytotoxic CD4+ T cells specific for Francisella tularensis.

Authors:  H M Surcel; S Tapaninaho; E Herva
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

7.  Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis.

Authors:  S Peppoloni; L Nencioni; A Di Tommaso; A Tagliabue; P Parronchi; S Romagnani; R Rappuoli; M T De Magistris
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

8.  In the presence of dexamethasone, gamma interferon induces rat oligodendrocytes to express major histocompatibility complex class II molecules.

Authors:  K Bergsteindottir; A Brennan; K R Jessen; R Mirsky
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

9.  In vivo lymphokine production in experimental autoimmune uveoretinitis.

Authors:  D G Charteris; S L Lightman
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

10.  Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.

Authors:  H M Cherwinski; J H Schumacher; K D Brown; T R Mosmann
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.